H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer Statistics 2020, GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209–249 (2021). https://doi.org/10.3322/caac.21660

Article  CAS  Google Scholar 

C.D. Dinardo, H.P. Erba, S.D. Freeman, A.H. Wei, Acute myeloid leukaemia. Lancet (London England). 401, 2073–2086 (2023). https://doi.org/10.1016/S0140-6736(23)00108-3

Article  CAS  PubMed  Google Scholar 

M. Onciu, Acute lymphoblastic leukemia. Hematol. Oncol. Clin. N. Am. 23, 655–674 (2009). https://doi.org/10.1016/j.hoc.2009.04.009

Article  Google Scholar 

A.-S.W.I. Cribe, M. Steenhof, C.W. Marcher, H. Petersen, H. Frederiksen, L.S. Friis, Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET. Eur. J. Haematol. 90, 273–278 (2013). https://doi.org/10.1111/ejh.12085

Article  CAS  PubMed  Google Scholar 

F. Stölzel, T. Lüer, S. Löck, S. Parmentier, F. Kuithan, M. Kramer, N.S. Alakel, K. Sockel, F. Taube, J.M. Middeke, J. Schetelig, C. Röllig, T. Paulus, J. Kotzerke, G. Ehninger, M. Bornhäuser, M. Schaich, K. Zoephel, The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial. Haematologica. 105, 1552–1558 (2020). https://doi.org/10.3324/haematol.2019.223032

Article  PubMed  PubMed Central  Google Scholar 

J. Hillengass, S. Usmani, S.V. Rajkumar, B.G.M. Durie, M.-V. Mateos, S. Lonial, C. Joao, K.C. Anderson, R. García-Sanz, E. Riva, J. Du, N. Van De Donk, J.G. Berdeja, E. Terpos, E. Zamagni, R.A. Kyle, J. San Miguel, H. Goldschmidt, S. Giralt, S. Kumar, N. Raje, H. Ludwig, E. Ocio, R. Schots, H. Einsele, F. Schjesvold, W.-M. Chen, N. Abildgaard, B.C. Lipe, D. Dytfeld, B.M. Wirk, M. Drake, M. Cavo, J.J. Lahuerta, S. Lentzsch, International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 20, e302–e312 (2019). https://doi.org/10.1016/S1470-2045(19)30309-2

Article  PubMed  Google Scholar 

J.V. Alvarez, G.K. Belka, T.-C. Pan, C.-C. Chen, E. Blankemeyer, A. Alavi, J.S. Karp, L.A. Chodosh, Oncogene pathway activation in mammary tumors dictates FDG-PET uptake. Cancer Res. 74, 7583–7598 (2014). https://doi.org/10.1158/0008-5472.CAN-14-1235

Article  CAS  PubMed  PubMed Central  Google Scholar 

P. Seam, M.E. Juweid, B.D. Cheson, The role of FDG-PET scans in patients with lymphoma. Blood. 110, 3507–3516 (2007). https://doi.org/10.1182/blood-2007-06-097238

Article  CAS  PubMed  Google Scholar 

E. Zamagni, C. Nanni, F. Patriarca, E. Englaro, P. Castellucci, O. Geatti, P. Tosi, P. Tacchetti, D. Cangini, G. Perrone, M. Ceccolini, A. Brioli, S. Buttignol, R. Fanin, E. Salizzoni, M. Baccarani, S. Fanti, M. Cavo, A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. 92, 50–55 (2007). https://doi.org/10.3324/haematol.10554

Article  PubMed  Google Scholar 

H.J. Cho, S.-H. Jung, J.-C. Jo, Y.J. Lee, S.E. Yoon, S.-S. Park, D.Y. Kim, H.-J. Shin, Y.-C. Mun, J.H. Yi, H.J. Kim, D.J. Kim, H.S. Lee, S.H. Bae, C.M. Hong, S.Y. Jeong, J.-J. Min, S.K. Sohn, C.-K. Min, K. Kim, J.-J. Lee, J.H. Moon, K.M.M.W. Party, Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT. Blood Cancer J. 11, 190 (2021). https://doi.org/10.1038/s41408-021-00577-2

Article  PubMed  PubMed Central  Google Scholar 

M.A. Aljama, M.H. Sidiqi, F.K. Buadi, M.Q. Lacy, M.A. Gertz, A. Dispenzieri, D. Dingli, E. Muchtar, A.L. Fonder, S.R. Hayman, M.A. Hobbs, W.I. Gonsalves, R.M. Warsame, T. Kourelis, Y.L. Hwa, P. Kapoor, R.A. Kyle, N. Leung, R.S. Go, S.V. Rajkumar, S.K. Kumar, Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma. Am. J. Hematol. 93, 1518–1523 (2018). https://doi.org/10.1002/ajh.25279

Article  CAS  PubMed  Google Scholar 

C. Ganzel, J. Manola, D. Douer, J.M. Rowe, H.F. Fernandez, E.M. Paietta, M.R. Litzow, J.-W. Lee, S.M. Luger, H.M. Lazarus, L.D. Cripe, P.H. Wiernik, M.S. Tallman, Extramedullary Disease in Adult Acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN Cancer Research Group trials, 1980–2008. J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol. 34, 3544–3553 (2016). https://doi.org/10.1200/JCO.2016.67.5892

Article  Google Scholar 

J.C. Byrd, R.B. Weiss, D.C. Arthur, D. Lawrence, M.R. Baer, F. Davey, E.S. Trikha, A.J. Carroll, R. Tantravahi, M. Qumsiyeh, S.R. Patil, J.O. Moore, R.J. Mayer, C.A. Schiffer, C.D. Bloomfield, Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol. 15, 466–475 (1997). https://doi.org/10.1200/JCO.1997.15.2.466

Article  CAS  Google Scholar 

I. Cunningham, B. Kohno, 18 FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases. Am. J. Hematol. 91, 379–384 (2016). https://doi.org/10.1002/ajh.24287

Article  PubMed  Google Scholar 

Z. Zhao, Y. Hu, J. Li, Y. Zhou, B. Zhang, S. Deng, Applications of PET in diagnosis and prognosis of Leukemia. Technol. Cancer Res. Treat. 19, 1–12 (2020). https://doi.org/10.1177/1533033820956993

Article  CAS  Google Scholar 

H. Chang, J. Brandwein, Q.-L. Yi, K. Chun, B. Patterson, B. Brien, Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk. Res. 28, 1007–1011 (2004). https://doi.org/10.1016/j.leukres.2004.01.006

Article  CAS  PubMed  Google Scholar 

M.L. Sorror, B.E. Storer, A.T. Fathi, A.T. Gerds, B.C. Medeiros, P. Shami, A.M. Brunner, M.A. Sekeres, S. Mukherjee, E. Peña, M. Elsawy, S. Wardyn, J. Whitten, R. Moore, P.S. Becker, J.S. Mccune, F.R. Appelbaum, E.H. Estey, Development and validation of a Novel Acute myeloid leukemia-composite model to Estimate risks of Mortality. JAMA Oncol. 3, 1675–1682 (2017). https://doi.org/10.1001/jamaoncol.2017.2714

Article  PubMed  PubMed Central  Google Scholar 

W. Wulaningsih, L. Holmberg, H. Garmo, H. Malmstrom, M. Lambe, N. Hammar, G. Walldius, I. Jungner, T. Ng, M.V. Hemelrijck, Serum lactate dehydrogenase and survival following cancer diagnosis. Br. J. Cancer. 113, 1389–1396 (2015). https://doi.org/10.1038/bjc.2015.361

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Paschali, E. Panagiotidis, T. Triantafyllou, V. Palaska, K. Tsirou, E. Verrou, E. Υiannaki, D. Markala, A. Papanikolaou, A. Pouli, P. Konstantinidou, V. Chatzipavlidou, E. Terpos, E. Katodritou, A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy. Eur. J. Nucl. Med. Mol. Imaging. 48, 1487–1497 (2021). https://doi.org/10.1007/s00259-020-05078-1

Article  CAS  PubMed  Google Scholar 

T. Endo, N. Sato, K. Koizumi, M. Nishio, K. Fujimoto, T. Sakai, K. Kumano, M. Obara, K. Minauchi, T. Koike, Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia. Am. J. Hematol. 76, 279–282 (2004). https://doi.org/10.1002/ajh.20106

Article  CAS  PubMed  Google Scholar 

T. Maeda, S. Kosugi, H. Ujiie, K. Osumi, T. Fukui, H. Yoshida, H. Kashiwagi, J. Ishikawa, Y. Tomiyama, Y. Matsuzawa, Localized relapse in bone marrow in a posttransplantation patient with t(6;9) acute myeloid leukemia. Int. J. Hematol. 77, 522–525 (2003). https://doi.org/10.1007/BF02986623

Article  PubMed  Google Scholar 

H. Döhner, A.H. Wei, F.R. Appelbaum, C. Craddock, C.D. Dinardo, H. Dombret, B.L. Ebert, P. Fenaux, L.A. Godley, R.P. Hasserjian, R.A. Larson, R.L. Levine, Y. Miyazaki, D. Niederwieser, G. Ossenkoppele, C. Röllig, J. Sierra, E.M. Stein, M.S. Tallman, H.-F. Tien, J. Wang, A. Wierzbowska, B. Löwenberg, Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 140, 1345–1377 (2022). https://doi.org/10.1182/blood.2022016867

Article  CAS  PubMed  Google Scholar 

N. Gökbuget, N. Boissel, S. Chiaretti, H. Dombret, M. Doubek, A. Fielding, R. Foà, S. Giebel, D. Hoelzer, M. Hunault, D.I. Marks, G. Martinelli, O. Ottmann, A. Rijneveld, P. Rousselot, J. Ribera, R. Bassan, Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood, 1903–1930 (2024). https://doi.org/10.1182/blood.2023023568